Related Experiment Videos
Targeting key steps in metastatic tumour progression
1Tumour Biology and Metastasis, Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research, McElwain Laboratories, Cotswold Road, Belmont, Sutton, Surrey, SM2 5NG, UK. sue.eccles@icr.ac.uk
Current Opinion in Genetics & Development
|January 22, 2005
Summary
Tumor progression involves new blood vessel growth (neoangiogenesis) and cell invasion. Targeting cell motility and chemotaxis offers novel therapeutic strategies for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tumor progression is driven by neoangiogenesis and metastasis.
- Malignant lesions possess distinct genetic regulation and signaling pathways.
- Cell motility and chemotaxis are crucial for tumor invasion and angiogenesis.
Purpose of the Study:
- To highlight the role of neoangiogenesis and metastasis in tumor progression.
- To identify common signaling pathways regulating these processes.
- To explore cell motility and chemotaxis as potential therapeutic targets.
Main Methods:
- Review of current literature on tumor progression mechanisms.
- Analysis of genetic regulation in oncogenesis and metastasis.
- Investigation of signaling pathways involved in cell motility and angiogenesis.
Main Results:
- Neoangiogenesis and cellular invasion are key to tumor progression.
- Specific genes and common signaling pathways co-ordinately regulate these processes.
- Cell motility and chemotaxis are critical for both tumor invasion and endothelial cell response.
Conclusions:
- Targeting cell motility and chemotaxis presents novel therapeutic opportunities.
- Understanding these pathways can lead to new interventions for cancer treatment.
- Further research into these mechanisms is warranted for effective cancer therapy.